perindopril has been researched along with Alloxan Diabetes in 47 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 11 (23.40) | 18.2507 |
2000's | 25 (53.19) | 29.6817 |
2010's | 11 (23.40) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baranska, M; Buczek, E; Chlopicki, S; Fedorowicz, A; Malek, K; Mateuszuk, L; Staniszewska-Slezak, E; Wiercigroch, E | 1 |
Annaratone, L; Barutta, F; Bellini, S; Bruno, G; Corbetta, B; di Marzo, V; Gambino, R; Gruden, G; Makriyannis, A; Mastrocola, R; Piscitelli, F; Vemuri, VK | 1 |
Jakjovski, K; Labacevski, N; Petrusevska, G; Trojacanec, J; Trojacanec, P; Zafirov, D; Zdravkovski, P | 1 |
Bhadada, SV; Patel, BM | 1 |
Başar, M; Ertürküner, SP; Seçkin, İ; Tunçdemir, M | 1 |
Öztürk, M; Tunçdemir, M | 1 |
Gilbert, RE; Kelly, DJ; Langham, RG; Tiauw, V; Wiggins, KJ; Zhang, Y | 1 |
Gao, L; Yu, DM | 1 |
Cho, CS; Kim, JH; Kim, KW; Yu, YS | 1 |
Chen, H; Fan, Y; Gu, Q; Ho, PC; Ke, G; Sun, X; Xu, X; Zheng, Z; Zou, H | 1 |
Cheng, XY; Ge, N; Li, SM; Li, YY; Lu, JD; Shao, MM; Sun, HL; Sun, L | 1 |
Cheng, S; Li, H; Li, J; Li, X; Qi, C; Xu, G; Yuan, L | 1 |
Li, X; Qi, CJ; Xu, GL; Yuan, L | 1 |
Hu, F; Liu, L; Shu, XC; Sun, HL; Sun, L; Sun, Y; Wen, JH; Yang, Q; Yin, DC; Zeng, YJ | 1 |
Chan, JS; Chenier, I; Filep, JG; Godin, N; Ingelfinger, JR; Liu, F; Lo, CS; Maachi, H; Shi, Y; Zhang, SL | 1 |
Agarwal, SS; Bhadada, SV; Patel, BM | 1 |
Ahola, A; Cooper, ME; Forsblom, C; Gordin, D; Groop, PH; Harjutsalo, V; Moran, J; Pickering, RJ; Saraheimo, M; Thomas, MC; Thorn, L; Tikellis, C; Tolonen, N; Tsorotes, D; Wadén, J | 1 |
Chen, X; Liu, SK; You, JL; Zhou, M | 1 |
Wu, XY; Zhong, HJ; Zhou, M | 1 |
Armitage, JA; Bui, BV; Cooper, ME; Tolcos, M; Vingrys, AJ | 1 |
Allen, TJ; Burns, WC; Burrell, LM; Cao, Z; Cooper, ME; Davis, BJ; Johnston, CI; Kubota, E | 1 |
Burns, WC; Cooper, ME; Tikellis, C; Tolcos, M; Twigg, SM | 1 |
Allen, TJ; Burns, WC; Cooper, ME; Davis, BJ; Forbes, JM; Jerums, G; Kawachi, H; Thomas, MC | 1 |
Gilbert, RE; Kelly, DJ; Koji, T; Maguire, J; Stein-Oakley, A; Thomson, N; Wassef, L; Wilkinson-Berka, JL; Zhang, Y | 1 |
Biswas, SK; de Faria, JB; de Faria, JM | 1 |
Erensoy, N; Hatemi, H; Oztürk, M; Tunçdemir, M; Uysal, O; Yilmazer, S | 1 |
Damgé, C; Daussin, F; Geny, B; Helms, P; Piquard, F; Rasseneur, L; Rouyer, O; Talha, S; Zoll, J | 1 |
Brezniceanu, ML; Chan, JS; Chénier, I; Filep, JG; Ingelfinger, JR; Liu, F; Sachetelli, S; Wei, CC; Zhang, SL | 1 |
Bialkowski, K; Cooper, ME; Johnston, C; Pete, J; Sheehy, K; Su, Q; Thomas, MC; Tikellis, C | 1 |
Cohen, R; Emonnot, L; Lo, M | 1 |
Cooper, ME; Doyle, AE; Rumble, JR | 1 |
Chou, ST; Cooper, ME; Du, HC; Jandeleit, K; Komers, R; Rumble, J | 1 |
Cooper, ME; Doyle, AE; Jerums, G; O'Brien, RC | 1 |
Cooper, M; Gin, T; Jerums, G; Joon, TL; Panagiotopoulos, S; Taylor, H | 1 |
Charlesworth, JA; Duggan, KA; Hodge, G; Makarious, MM | 2 |
Liu, Y; Lu, J; Pan, C | 1 |
Allen, TJ; Cao, Z; Cooper, ME; Gilbert, RE; Jandeleit, K; Rumble, JR | 1 |
Cheng, H; Fu, Z; Yan, L; Yan, T; Yang, R; Zhong, G | 1 |
Cooper, ME; Cox, AJ; Gilbert, RE; Hendrich, EC; Jerums, G; Kelly, DJ; Lee, V; Osicka, T; Panagiotopoulos, S; Rumble, JR; Wilkinson-Berka, JL | 1 |
Cooper, ME; Gibbs, NJ; Kelly, DJ; Skinner, SL; Wilkinson-Berka, JL | 1 |
Cooper, ME; Cox, AJ; Gilbert, RE; Kelly, DJ; Tolcos, M; Wilkinson-Berka, JL | 1 |
Cox, AJ; Gilbert, RE; Kelly, DJ; Ricardo, SD; Wilkinson-Berka, JL | 1 |
Allen, TJ; Burns, WC; Candido, R; Cao, Z; Cooper, ME; Dilley, RJ; Jandeleit-Dahm, KA; Nesteroff, SP; Twigg, SM | 1 |
Aaltonen, P; Cox, AJ; Gilbert, RE; Holthöfer, H; Jerums, G; Kelly, DJ; Langham, R; Panagiotopoulos, S; Rumble, JR | 1 |
Cooper, ME; Gin, T; Lim-Joon, T; Rumble, JR | 1 |
Allen, TJ; Cooper, ME; Doyle, AE; Jerums, G; O'Brien, RC; Rumble, JR | 1 |
47 other study(ies) available for perindopril and Alloxan Diabetes
Article | Year |
---|---|
A possible Fourier transform infrared-based plasma fingerprint of angiotensin-converting enzyme inhibitor-induced reversal of endothelial dysfunction in diabetic mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Chemical Analysis; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Endothelium; Mice; Perindopril; Spectroscopy, Fourier Transform Infrared | 2018 |
Reversal of albuminuria by combined AM6545 and perindopril therapy in experimental diabetic nephropathy.
Topics: Albuminuria; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Male; Mice; Mice, Inbred C57BL; Morpholines; Perindopril; Pyrazoles; Receptor, Cannabinoid, CB1 | 2018 |
Perindopril treatment in streptozotocin induced diabetic nephropaty.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Blood Urea Nitrogen; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Glomerulonephritis; Hypertrophy; Kidney; Male; Perindopril; Rats, Wistar; Streptozocin; Time Factors | 2013 |
Type 2 diabetes-induced cardiovascular complications: comparative evaluation of spironolactone, atenolol, metoprolol, ramipril and perindopril.
Topics: Animals; Animals, Newborn; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Metoprolol; Perindopril; Ramipril; Rats, Wistar; Spironolactone | 2014 |
The comparative effects of perindopril and catechin on mesangial matrix and podocytes in the streptozotocin induced diabetic rats.
Topics: Albuminuria; Animals; Blood Glucose; Catechin; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glomerular Mesangium; Male; Microscopy, Electron; Perindopril; Podocytes; Rats; Rats, Wistar; Streptozocin; Transforming Growth Factor beta1 | 2014 |
Regulation of the Ku70 and apoptosis-related proteins in experimental diabetic nephropathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Biphenyl Compounds; Blood Glucose; Caspase 3; Cytochromes c; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Irbesartan; Kidney; Kidney Glomerulus; Kidney Tubules; Ku Autoantigen; Male; Perindopril; Rats; Rats, Wistar; Tetrazoles | 2016 |
Perindopril attenuates tubular hypoxia and inflammation in an experimental model of diabetic nephropathy in transgenic Ren-2 rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Fibrosis; Hypoxia; Immunohistochemistry; Inflammation; Kidney Tubules; Macrophages; Nitroimidazoles; Osteopontin; Perindopril; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Renin-Angiotensin System; Time Factors | 2008 |
Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Extremities; Fibroblast Growth Factor 2; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase Type III; Perindopril; Rats; Rats, Wistar; RNA, Messenger; Streptozocin; Vascular Endothelial Growth Factor A | 2008 |
Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood-Retinal Barrier; Capillary Permeability; Cell Line; Dextrans; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Fluoresceins; Humans; Mice; Mice, Inbred C57BL; Perindopril; Retina; Tight Junctions; Vascular Endothelial Growth Factor A | 2009 |
Protective effect of perindopril on diabetic retinopathy is associated with decreased vascular endothelial growth factor-to-pigment epithelium-derived factor ratio: involvement of a mitochondria-reactive oxygen species pathway.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cattle; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelium, Vascular; Eye Proteins; Glucose; Male; Membrane Potentials; Mitochondria; Mitochondrial Membranes; Nerve Growth Factors; Perindopril; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Retinal Vessels; Reverse Transcriptase Polymerase Chain Reaction; Serpins; Survivors; Vascular Endothelial Growth Factor A | 2009 |
ACE-inhibitor suppresses the apoptosis induced by endoplasmic reticulum stress in renal tubular in experimental diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Evaluation, Preclinical; eIF-2 Kinase; Endoplasmic Reticulum; Heat-Shock Proteins; Kidney Tubules; Male; Molecular Chaperones; Perindopril; Rats; Rats, Sprague-Dawley; Streptozocin; Stress, Physiological | 2009 |
Effect of renin angiotensin system blockade on the islet microvessel density of diabetic rats and its relationship with islet function.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Islets of Langerhans; Male; Microvessels; Perindopril; Random Allocation; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2009 |
Effects of renin-angiotensin system blockade on islet function in diabetic rats.
Topics: Angiotensinogen; Animals; Apoptosis; Diabetes Mellitus, Experimental; Glucose Tolerance Test; In Situ Nick-End Labeling; Islets of Langerhans; Male; Nitric Oxide Synthase Type II; Perindopril; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta1; Valine; Valsartan | 2010 |
Perindopril attenuates renal tubulointerstitium injury by inhibiting scavenger receptor A over-expression in diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Diabetes Mellitus, Experimental; Disease Models, Animal; Immunoenzyme Techniques; Kidney Tubules; Macrophages; Male; Perindopril; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Scavenger Receptors, Class A | 2012 |
Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Expression; Hypertension; Kidney; Kidney Tubules, Proximal; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nephrosclerosis; Peptidyl-Dipeptidase A; Perindopril; Rats; Renin-Angiotensin System; Transgenes | 2012 |
Perindopril protects against streptozotocin-induced hyperglycemic myocardial damage/alterations.
Topics: Animals; Animals, Newborn; Blood Glucose; Cardiomegaly; Cardiotonic Agents; Diabetes Mellitus, Experimental; Female; Glutathione; Hemodynamics; Lipids; Male; Malondialdehyde; Oxidative Stress; Perindopril; Rats; Rats, Wistar | 2012 |
Association of dietary sodium intake with atherogenesis in experimental diabetes and with cardiovascular disease in patients with Type 1 diabetes.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Animals; Apolipoproteins E; Atherosclerosis; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diet, Sodium-Restricted; Female; Finland; Humans; Male; Mice; Mice, Knockout; Middle Aged; Perindopril; Plaque, Atherosclerotic; Renin-Angiotensin System; Sodium; Sodium, Dietary | 2013 |
[Protective effect of perindopril on dysfunction of endothelium-dependent relaxation in diabetic rats].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Diabetes Mellitus, Experimental; Endothelium, Vascular; Male; Perindopril; Rats; Rats, Sprague-Dawley; Vasodilation | 2000 |
[Changes of ultrastructure and function of the aortic endothelium in streptozotocin-diabetic rats and effect of perindopril].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Diabetes Mellitus, Experimental; Endothelin-1; Endothelium, Vascular; Male; Perindopril; Random Allocation; Rats; Rats, Sprague-Dawley | 2001 |
ACE inhibition salvages the visual loss caused by diabetes.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Electroretinography; Guanidines; Perindopril; Photoreceptor Cells, Vertebrate; Rats; Rats, Sprague-Dawley; Retina; Vision Disorders | 2003 |
Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Hypertension; Immunohistochemistry; Kidney; Male; Membrane Proteins; Peptidyl-Dipeptidase A; Perindopril; Proteins; Rats; Rats, Inbred SHR; Reference Values | 2003 |
Connective tissue growth factor is up-regulated in the diabetic retina: amelioration by angiotensin-converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Gene Expression Regulation; Immediate-Early Proteins; Immunohistochemistry; In Situ Hybridization; Intercellular Signaling Peptides and Proteins; Male; Perindopril; Rats; Rats, Sprague-Dawley; Retina; Retinal Ganglion Cells; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Distribution | 2004 |
Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Drug Therapy, Combination; Enzyme Inhibitors; Guanidines; Kidney; Kidney Glomerulus; Male; Perindopril; Rats; Rats, Inbred SHR | 2004 |
Fas-induced apoptosis is a feature of progressive diabetic nephropathy in transgenic (mRen-2)27 rats: attenuation with renin-angiotensin blockade.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Fas Ligand Protein; fas Receptor; Female; Membrane Glycoproteins; Perindopril; Rats | 2004 |
Davis BJ, Forbes JM, Thomas MC et al. (2004) Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat. Diabetologia 47:89-97.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Guanidines; Nitric Oxide Synthase; Perindopril; Rats; Rats, Inbred SHR | 2004 |
Effects of ACE inhibition on the expression of type IV collagen and laminin in renal glomeruli in experimental diabetes.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Basement Membrane; Blood Glucose; Body Weight; Collagen Type IV; Diabetes Mellitus, Experimental; Fluorescent Antibody Technique, Indirect; Kidney Glomerulus; Kidney Tubules; Laminin; Male; Perindopril; Rats; Rats, Wistar | 2004 |
Effect of angiotensin-converting enzyme inhibition on skeletal muscle oxidative function and exercise capacity in streptozotocin-induced diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Cell Respiration; Diabetes Mellitus, Experimental; Insulin; Male; Mitochondria, Muscle; Muscle, Skeletal; Perindopril; Physical Conditioning, Animal; Rats; Rats, Wistar; Regional Blood Flow; Streptozocin | 2007 |
Overexpression of angiotensinogen increases tubular apoptosis in diabetes.
Topics: Albuminuria; Angiotensinogen; Animals; Antihypertensive Agents; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Blood Glucose; Cell Line, Transformed; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hydralazine; Hypertension, Renal; Hypoglycemic Agents; Insulin; Kidney Tubules, Proximal; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Perindopril; Rats; Renin-Angiotensin System | 2008 |
ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes.
Topics: Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptidyl-Dipeptidase A; Perindopril | 2008 |
Renal and metabolic disorders depend on the renin-angiotensin system in Lyon hypertensive rats associated with diabetes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Hyperlipidemias; Hypertension; Kidney Diseases; Male; Perindopril; Proteinuria; Rats; Renin-Angiotensin System | 2008 |
Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes.
Topics: Albuminuria; Animals; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Dihydropyridines; Disease Models, Animal; Hypertension; Indoles; Kidney Diseases; Male; Perindopril; Random Allocation; Rats; Rats, Inbred SHR; Renin | 1995 |
Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Hypertrophy; Indoles; Insulin; Male; Muscle, Smooth, Vascular; Perindopril; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Splanchnic Circulation | 1994 |
The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Glomerular Filtration Rate; Glomerular Mesangium; Hydralazine; Hydrochlorothiazide; Indoles; Kidney Glomerulus; Male; Perindopril; Rats; Rats, Sprague-Dawley; Reserpine | 1993 |
Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dihydropyridines; Drug Therapy, Combination; Hydralazine; Hydrochlorothiazide; Hypertension, Renal; Indoles; Kidney; Male; Organ Specificity; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reserpine; Retina; Serum Albumin | 1996 |
Acute but not chronic angiotensin-converting enzyme inhibition induces enzyme synthesis in the glomerulus of the spontaneously hypertensive rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Administration Schedule; Enzyme Induction; Female; Indoles; Kidney Glomerulus; Peptidyl-Dipeptidase A; Perindopril; Rats; Rats, Inbred SHR | 1997 |
[The influence of perindopril on intrarenal RAS in experimental diabetic rats].
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Diabetes Mellitus, Experimental; Indoles; Kidney; Male; Perindopril; Rats; Rats, Wistar; Renin-Angiotensin System; RNA, Messenger | 1996 |
Renoprotective differences between perindopril and enalapril in the diabetic hypertensive rat do not reflect glomerular angiotensin-converting enzyme activity.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enalapril; Indoles; Kidney Glomerulus; Peptidyl-Dipeptidase A; Perindopril; Proteins; Random Allocation; Rats; Rats, Inbred SHR | 1998 |
Attenuation of diabetes-associated mesenteric vascular hypertrophy with perindopril: morphological and molecular biological studies.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Vessels; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Hypertrophy; Indoles; Male; Perindopril; Rats; Rats, Sprague-Dawley; RNA, Messenger; Splanchnic Circulation; Transforming Growth Factor beta | 1998 |
Protective effect of the angiotensin-converting enzyme inhibitor perindopril on diabetic glomerulopathy in streptozotocin-induced diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Indoles; Male; Perindopril; Random Allocation; Rats; Rats, Wistar | 1998 |
Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Northern; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Growth Factors; Gene Expression; In Situ Hybridization; Lymphokines; Male; Perindopril; Ramipril; Rats; Rats, Sprague-Dawley; Retina; Retinal Vessels; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Renoprotective and anti-hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic (mRen-2)27 rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Drug Therapy, Combination; Female; Heterozygote; Kidney; Perindopril; Rats; Renin; Tetrazoles; Valine; Valsartan | 2001 |
Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Apoptosis; Atrophy; Autoradiography; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epidermal Growth Factor; Female; Fibrosis; Gene Expression; In Situ Hybridization; In Situ Nick-End Labeling; Kidney Tubules; Nephritis, Interstitial; Perindopril; Rats; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Valine; Valsartan | 2002 |
Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Female; Humans; Kidney; Kidney Tubules; Macrophages; Osteopontin; Perindopril; Rats; Renin; Sialoglycoproteins; Transcription, Genetic | 2002 |
Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice.
Topics: Actins; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Apolipoproteins E; Arteriosclerosis; Collagen; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Disease Progression; Growth Substances; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Perindopril; Phagocytes; Proliferating Cell Nuclear Antigen; RNA, Messenger; Vascular Cell Adhesion Molecule-1 | 2002 |
Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Base Sequence; Diabetes Mellitus, Experimental; Diabetic Nephropathies; DNA Primers; Guanidines; In Situ Hybridization; Male; Membrane Proteins; Mutation; Perindopril; Proteins; Proteinuria; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2002 |
Diabetic renal microvascular disease: the role of hypertension and ACE inhibitors.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Nephropathies; Dihydropyridines; Hypertension, Renovascular; Indoles; Kidney Glomerulus; Male; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1992 |
Antihypertensive therapy in a model combining spontaneous hypertension with diabetes.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Drug Combinations; Glomerular Filtration Rate; Hydralazine; Hydrochlorothiazide; Hypertension; Indoles; Male; Perindopril; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Reserpine | 1992 |